Trial intelligence / Profile preview

Open-label phase 3 evaluation of IONSYS fentanyl for acute postoperative pain in adolescents

2014-002405-37Phase 3

Sponsor
Incline Therapeutics
Start
Nov 2016
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, open-label, single-arm trial of fentanyl iontophoretic transdermal system in postoperative pain, sponsored by Incline Therapeutics. Primary endpoint: Safety endpoints.

02

Drugs

fentanyl iontophoretic transdermal system
03

Conditions

postoperative pain

Beyond the preview

Go deeper on 2014-002405-37.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2014-002405-37.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call